Home > Archive>Volume 17, Issue 12, 2024 >2203-2213. DOI:10.18240/ijo.2024.12.07
PDF HTML XML Export Cite reminder
Guidelines for the standardized diagnosis and treatment of non-specific orbital inflammation (2024)
Author:
Corresponding Author:

Yi Shao. Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai 200080, China. freebee99@163.com; Jian-Min Ma. Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing 100005, China. jmma@sina.com; Hua-Sheng Yang. Zhongshan Ophthalmic Centre, Sun Yat-sen University, Guangzhou 510060, Guangdong Province, China. Yanghs64@126.com.

Fund Project:

Supported by National Natural Science Foundation of China (No.82160195; No.82460203); Jiangxi Double-Thousand Plan High-Level Talent Project of Science and Technology Innovation (No.jxsq2023201036); Key R&D Program of Jiangxi Province (No.20223BBH80014).

  • Article
    • | |
  • Metrics
    • |
  • Reference [49]
    • |
  • Related [20]
    • | | |
  • Comments
    Abstract:

    Non-specific orbital inflammation (NSOI) is a non-infectious orbital inflammation. Although it is often considered the most common diagnosis in orbital biopsies, it is an exclusionary diagnosis that requires ruling out systemic disease or other possible causes. Its characteristics include acute orbital signs and symptoms, including pain, proptosis, periorbital edema, chemosis, diplopia, and visual impairment. The clinical manifestations and histological findings of NSOI are heterogeneous, without specific diagnostic criteria or treatment guidelines, which poses significant challenges for diagnosis and treatment. This guideline provides a detailed description of the definition, classification, diagnosis, and treatment of NSOI.

    Reference
    1 Birch-Hirschfeld A. Diagnosis of the benign and malignant tumors of the orbit. Der Deutsch Ophthalmol Ges 1905;32:127-135.
    2 Grove AS Jr, Weber AL. Orbital pseudotumor—historical origin and modern relevance. Ophthalmic Plast Reconstr Surg 2013;29(5):341-346.
    3 Swamy BN, McCluskey P, Nemet A, Crouch R, Martin P, Benger R, Ghabriel R, Wakefield D. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol 2007;91(12):1667-1670.
    4 Shields JA, Shields CL. Orbital pseudotumor versus idiopathic nongranulomatous orbital inflammation. Ophthalmic Plast Reconstr Surg 2013;29(5):349.
    5 Günalp I, Gündüz K, Yazar Z. Idiopathic orbital inflammatory disease. Acta Ophthalmol Scand 1996;74(2):191-193.
    6 Jacobs D, Galetta S. Diagnosis and management of orbital pseudotumor. Curr Opin Ophthalmol 2002;13(6):347-351.
    7 Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: The 2005 ASOPRS Foundation Lecture. Ophthalmic Plast Reconstr Surg 2006;22(2):79-86.
    8 Chaudhry IA, Shamsi FA, Arat YO, Riley FC. Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol 2008;15(1):17-27.
    9 Spindle J, Tang SX, Davies B, Wladis EJ, Piozzi E, Pellegrini M, Lally SE, Shields C, Shinder R. Pediatric idiopathic orbital inflammation: clinical features of 30 cases. Ophthalmic Plast Reconstr Surg 2016;32(4):270-274.
    10 Braich PS, Kuriakose RK, Khokhar NS, Donaldson JC, McCulley TJ. Factors associated with multiple recurrences of nonspecific orbital inflammation aka orbital pseudotumor. Int Ophthalmol 2018;38(4):1485-1495.
    11 Young SM, Chan ASY, Jajeh IA, Shen S, Seah LL, Choo CT, Lang SS, Looi ALG. Clinical features and treatment outcomes of orbital inflammatory disease in Singapore: a 10-year clinicopathologic review. Ophthalmic Plast Reconstr Surg 2017;33(3):182-188.
    12 Rootman J, Nugent R. The classification and management of acute orbital pseudotumors. Ophthalmology 1982;89(9):1040-1048.
    13 Mombaerts I, Goldschmeding R, Schlingemann RO, Koornneef L. What is orbital pseudotumor? Surv Ophthalmol 1996;41(1):66-78.
    14 Luemsamran P, Rootman J, White VA, Nassiri N, Heran MKS. The role of biopsy in lacrimal gland inflammation: a clinicopathologic study. Orbit 2017;36(6):411-418.
    15 Zhao Y, Cai F, Liu H, Niu M, Zhi L, Liu C, Wang Y, Wang J, Wang H. Analysis of clinicopathological characteristics of adult orbital xlogranulomatosis. Int Eye Sci (Guoji Yanke Zazhi) 2022;22(01): 158-162.
    16 Zaldivar Villon MLF, de la Rocha JAL, Espinoza LR. Takayasu arteritis: recent developments. Curr Rheumatol Rep 2019;21(9):45.
    17 Şovrea AS, Bartoş DM, Bartoş A, Dronca E, Szabo BA. Solitary Langerhans Histiocytosis of the orbit: case report and review of the literature. Rom J Morphol Embryol 2017;58(4):1589-1595.
    18 Pemberton JD, Fay A. Idiopathic sclerosing orbital inflammation: a review of demographics, clinical presentation, imaging, pathology, treatment, and outcome. Ophthalmic Plast Reconstr Surg 2012;28(1): 79-83.
    19 Bijlsma WR, Van’t Hullenaar FC, Mourits MP, Kalmann R. Evaluation of classification systems for nonspecific idiopathic orbital inflammation. Orbit 2012;31(4):238-245.
    20 Pinard CL. Diagnostic tests used during the ocular examination. Vet Clin North Am Small Anim Pract 2023;53(2):279-298.
    21 Tsukikawa M, Lally SE, Shields CL, Eagle RC Jr, Ellis FJ, Wasserman BN. Idiopathic orbital pseudotumor preceding systemic inflammatory disease in children. J Pediatr Ophthalmol Strabismus 2019;56(6): 373-377.
    22 Suzuki N, Noh JY, Kameda T, et al. Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease. Clin Ophthalmol 2018;12:739-746.
    23 Katz G, Stone JH. Clinical perspectives on IgG4-related disease and its classification. Annu Rev Med 2022;73:545-562.
    24 André F, Böckle BC. Sjögren’s syndrome. J Dtsch Dermatol Ges 2022;20(7):980-1002.
    25 Mombaerts I, Rose GE, Garrity JA. Orbital inflammation: biopsy first. Surv Ophthalmol 2016;61(5):664-669.
    26 Ding ZX, Lip G, Chong V. Idiopathic orbital pseudotumour. Clin Radiol 2011;66(9):886-892.
    27 Hardman JA, Halpin SF, Mars S, Hourihan MD, Lane CM. MRI of idiopathic orbital inflammatory syndrome using fat saturation and Gd-DTPA. Neuroradiology 1995;37(6):475-478.
    28 Cohen LM, Yoon MK. Update on current aspects of orbital imaging: CT, MRI, and ultrasonography. Int Ophthalmol Clin 2019;59(4):69-79.
    29 Mendenhall WM, Lessner AM. Orbital pseudotumor. Am J Clin Oncol 2010;33(3):304-306.
    30 Perez FA. Imaging of nontraumatic orbital and neuro-ophthalmological emergencies. Semin Roentgenol 2020;55(2):132-149.
    31 Ronquillo Y, Zeppieri M, Patel BC. Nonspecific Orbital Inflammation. 2024 May 6. In: StatPearls. Treasure Island (FL):StatPearls Publishing; 2024.
    32 Carruth BP, Wladis EJ. Inflammatory modulators and biologic agents in the treatment of idiopathic orbital inflammation. Curr Opin Ophthalmol 2012;23(5):420-426.
    33 Wu KY, Kulbay M, Daigle P, Nguyen BH, Tran SD. Nonspecific orbital inflammation (NSOI):unraveling the molecular pathogenesis, diagnostic modalities, and therapeutic interventions. Int J Mol Sci 2024;25(3):1553.
    34 Eshraghi B, Sonbolestan SA, Abtahi MA, Mirmohammadsadeghi A. Clinical characteristics, histopathology, and treatment outcomes in adult and pediatric patients with nonspecific orbital inflammation. J Curr Ophthalmol 2019;31(3):327-334.
    35 Rubinov A, Zommer H, Aghazadeh H, Weis E. Role of methotrexate in thyroid-related orbitopathy. Can J Ophthalmol 2018;53(1):34-38.
    36 Macovei ML, Neacșu AM. Diagnostic and therapeutic challenges in non-specific orbital inflammation—a case report. Rom J Ophthalmol 2023;67(1):81-86.
    37 Starr MR, Garrity JA, Tooley AA, Salomão DR. Clinical and histopathological findings of patients with orbital granulomatosis with polyangiitis cases refractory to rituximab. Can J Ophthalmol 2019;54(6):682-687.
    38 Torres RP, Santos FP, Branco JC. Methotrexate: Implications of pharmacogenetics in the treatment of patients with Rheumatoid Arthritis. ARP Rheumatol 2022;1(3):225-229.
    39 Tille L, Schnabel A, Laass MW, Hahn G, Taut H, Leszczynska A, Pablik J, Berner R, Brück N, Hedrich CM. Orbital inflammation and colitis in pediatric IgG4-related disease: a case report and review of the literature. Eur J Rheumatol 2020;7(Suppl1):S21-S27.
    40 Fenech M, Ajanaku A, McCormick A, Coupland SE, Krishna Y, Sultan Z, Ghadiri N. Orbital Kimura disease: maintenance therapy using mycophenolate mofetil. Orbit 2024:1-8.
    41 Shen RF, Zeng FD, Shi SJ. Progress In the Pharmacological Effects and Clinical Application of Azathioprine. China Pharmacist 2013;16(09):1409-1412.
    42 Baslund B, Wiencke AK, Rasmussen N, Faurschou M, Toft PB. Treatment of orbital inflammation with rituximab in Wegener’s granulomatosis. Clin Exp Rheumatol 2012;30(1 Suppl 70): S7-S10.
    43 Ashkenazy N, Saboo US, Abraham A, Ronconi C, Cao JH. Successful treatment with infliximab after adalimumab failure in pediatric noninfectious uveitis. J Am Assoc Pediatr Ophthalmol Strabismus 2019;23(3):151.e1-151.e5.
    44 Ng CC, Sy A, Cunningham ET Jr. Rituximab for treatment of non-infectious and non-malignant orbital inflammatory disease. J Ophthalmic Inflamm Infect 2021;11(1):24.
    45 Xiong AJ, Liu D, Chen HN, Yang GC, Xiong C, Shuai Y, He LQ, Guo ZP, Zhang LW, Yang Y, Cui BB, Shuai SQ. The efficacy and safety of infliximab in refractory noninfectious uveitis: a meta-analysis of observational studies. Front Pharmacol 2021;12:620340.
    46 Ma JM, Zhang H. Common Orbital Inflammatory Diseases. Beijing: Science and Technology Press, 2022, First Edition, 35-36.
    47 Yang HS, Zhang T, Ye HJ. Selection of diagnosis and treatment methods for orbital inflammatory pseudotumor based on imaging classification. Chinese Journal of Ophthalmology 2023;59(1):8-12.
    48 Li SM, Lin Y, Liang SS. Efficacy of pirfenidone for the treatment of pulmonary fibrosis: an updated systematic review protocol of randomized controlled trial. Medicine 2019;98(17):e15407.
    49 Takahashi Y, Lee PAL, Vaidya A, Kono S, Kakizaki H. Tear film break-up patterns in thyroid eye disease. Sci Rep 2021;11:5288.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Yi Shao, Jian-Min Ma, Hua-Sheng Yang,/et al.Guidelines for the standardized diagnosis and treatment of non-specific orbital inflammation (2024). Int J Ophthalmol, 2024,17(12):2203-2213

Copy
Share
Article Metrics
  • Abstract:65
  • PDF: 252
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:July 02,2024
  • Revised:July 26,2024
  • Online: November 19,2024
You are the 4409364 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.